Identification of disease genes by exome sequencing by Sun, Yu
 
Cover Page 
 
 
 
 
 
 
 
 
The handle http://hdl.handle.net/1887/20682 holds various files of this Leiden University 
dissertation. 
 
Author: Sun, Yu 
Title: Identification of disease genes by exome sequencing 
Issue Date: 2013-03-26 
Stellingen/ Propositions 
Identification of Disease Genes by Exome Sequencing 
Yu Sun 
 
1. The identification of a disease-causing gene from exome/genome sequencing is a 
step wise process. When nothing is left, work backwards and reduce the thresholds 
set. This thesis 
2. Especially when technologies are still developing and one depends heavily on 
computational analysis it is worthwhile to look at the results, i.e. for exome 
sequencing, look at the alignment on your screen. This thesis 
3. Due to X-chromosome inactivation, the mutant c.5217G>A FLNA allele is not 
expressed in the fibroblasts of female patients with Terminal Osseous Dysplasia. The 
variant, activates a cryptic splice site, only expressed in fibroma cells. This thesis 
4. Loss of IGSF1 function will cause central hypothyroidism and testicular enlargement, 
likely secondary to an associated impairment in pituitary TRH signaling. This thesis 
5. To resolve cases with unknown genetic defects, besides digging deeper to reveal 
non-obvious variants, the isolation and analysis of RNA provides a simple and 
valuable yet largely under-appreciated tool. This thesis 
6. Exome capture and next generation DNA sequencing has been demonstrated to be a 
powerful diagnostic approach for heterogeneous diseases such as ataxia and 
Charcot-Marie-Tooth disease. A. Sailer and H. Houlden, Curr Neurol Neurosci Rep 12, 
227 (2012) 
7. False-positive calls frequently emerge from sequences that are polymorphic and/or 
present in several copies  (segmental duplications, processed pseudogenes, 
sequences present in some genomes but not in others, etc.) Variant calling should 
therefore not be performed without checking coverage (copy number).  
8. Evolutionary conservation, population frequency, segregation, absence in healthy 
controls/presence in patients, computer predictions, etc. can all be used to classify 
variants as disease-causing or not, yet only experimental proof from functional 
analysis can settle the case. 1000 Genomes Project Consortium, Nature 491, 56 
(2012); Y.Xue et al., American Journal of Human Genetics 91, 1022(2012) 
9. Sample preparation and data analysis are complementary to each other. They both 
help to understand the technology.  
10. The best is yet to come.  
11. Good tools are a prerequisite to the successful execution of a job. Analects, 
Confucius 
